{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:58:52Z","timestamp":1790125132128,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203209"],"award-info":[{"award-number":["82203209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472807"],"award-info":[{"award-number":["82472807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82421005"],"award-info":[{"award-number":["82421005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425038"],"award-info":[{"award-number":["82425038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3400902"],"award-info":[{"award-number":["2022YFC3400902"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218361","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:15:18Z","timestamp":1772583318000},"page":"218361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Targeting FGFR1-regulated SPP1 signaling repolarizes immunosuppressive macrophages and sensitizes Hepatocellular Carcinoma to anti-PD-1 therapy"],"prefix":"10.1016","volume":"646","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5702-427X","authenticated-orcid":false,"given":"Youhai","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingye","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218361_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41586-024-07050-7","article-title":"Deep whole-genome analysis of 494 hepatocellular carcinomas","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.canlet.2026.218361_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","article-title":"Precision treatment in advanced hepatocellular carcinoma","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"issue":"10360","key":"10.1016\/j.canlet.2026.218361_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.canlet.2026.218361_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","article-title":"Resistance mechanisms to Anti-PD cancer immunotherapy","volume":"40","author":"Vesely","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218361_bib6","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.ccell.2024.10.008","article-title":"Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.canlet.2026.218361_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2026.218361_bib8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.canlet.2026.218361_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccell.2023.12.013","article-title":"Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer","volume":"42","author":"Memon","year":"2024","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.canlet.2026.218361_bib10","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218361_bib11","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/gutjnl-2022-328364","article-title":"Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma","volume":"72","author":"Xiong","year":"2023","journal-title":"Gut"},{"issue":"6745","key":"10.1016\/j.canlet.2026.218361_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.adr3026","article-title":"Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity","volume":"388","author":"Chiu","year":"2025","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/gutjnl-2024-332902","article-title":"Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC","volume":"74","author":"Chen","year":"2025","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.canlet.2026.218361_bib15","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1158\/0008-5472.CAN-23-3106","article-title":"Repolarization of immunosuppressive macrophages by targeting SLAMF7-Regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy","volume":"84","author":"Weng","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218361_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101701","article-title":"Polyphenolic Proanthocyanidin-B2 suppresses proliferation of liver cancer cells and hepatocellular carcinogenesis through directly binding and inhibiting AKT activity","volume":"37","author":"Liu","year":"2020","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218361_bib17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage diversity in cancer revisited in the era of single-cell omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"issue":"17","key":"10.1016\/j.canlet.2026.218361_bib18","doi-asserted-by":"crossref","first-page":"E4041","DOI":"10.1073\/pnas.1720948115","article-title":"Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti\u2013PD-1 treatment","volume":"115","author":"Peranzoni","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.canlet.2026.218361_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.581395","article-title":"Silencing osteopontin expression inhibits proliferation, invasion and induce altered protein expression in Melanoma cells","volume":"27","author":"Kiss","year":"2021","journal-title":"Pathol. Oncol. Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1186\/s12967-024-06018-5","article-title":"Single-cell and spatial transcriptomics reveal SPP1-CD44 signaling drives primary resistance to immune checkpoint inhibitors in RCC","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-024-04947-9","article-title":"Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors","volume":"22","author":"Gui","year":"2024","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.canlet.2026.218361_bib25","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1007\/s10238-023-01229-4","article-title":"EMT-induced immune evasion: connecting the dots from mechanisms to therapy","volume":"23","author":"Imodoye","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"11","key":"10.1016\/j.canlet.2026.218361_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101208","article-title":"FGF9\/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer","volume":"14","author":"Chang","year":"2021","journal-title":"Transl. Oncol."},{"issue":"19","key":"10.1016\/j.canlet.2026.218361_bib27","first-page":"2388","article-title":"Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy","volume":"31","author":"Ulloa-Montoya","year":"2013","journal-title":"J. Clin. Orthod."},{"issue":"9","key":"10.1016\/j.canlet.2026.218361_bib28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","article-title":"Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer","volume":"52","author":"Cho","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"10064","key":"10.1016\/j.canlet.2026.218361_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-019-1326-5","article-title":"Recent advances in triple negative breast cancer: the immunotherapy era","volume":"17","author":"Marra","year":"2019","journal-title":"BMC Med."},{"issue":"24","key":"10.1016\/j.canlet.2026.218361_bib31","first-page":"2789","article-title":"Immunologic strategies in pancreatic cancer: making cold tumors Hot","volume":"40","author":"Ullman","year":"2022","journal-title":"J. Clin. Orthod."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41467-021-27833-0","article-title":"Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3K\u03b1\/\u03b2\/\u03b4 treatment","volume":"13","author":"Qi","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","article-title":"Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers","volume":"25","author":"Scheper","year":"2019","journal-title":"Nat. Med."},{"issue":"7738","key":"10.1016\/j.canlet.2026.218361_bib34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.canlet.2026.218361_bib35","article-title":"Lineage and ecology define liver tumor evolution in response to treatment","volume":"5","author":"Revsine","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"11","key":"10.1016\/j.canlet.2026.218361_bib36","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","article-title":"A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer","volume":"188","author":"Liu","year":"2025","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.canlet.2026.218361_bib37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to Anti-PD-1 monotherapy and Anti-PD-1\/Anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-023-01761-7","article-title":"Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF\/FGFR signaling in tumor microenvironment","volume":"22","author":"Ruan","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2026.218361_bib39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41571-024-00869-z","article-title":"FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions","volume":"21","author":"Katoh","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"62","key":"10.1016\/j.canlet.2026.218361_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001451","article-title":"Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer","volume":"2","author":"Weiss","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.canlet.2026.218361_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/modpathol.2013.141","article-title":"Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer","volume":"27","author":"Schultheis","year":"2014","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13058-021-01398-8","article-title":"FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4\/6, and FGFR1","volume":"23","author":"Mouron","year":"2021","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12672-024-01723-5","article-title":"The molecular mechanism of gemcitabine in inhibiting the HIF-1\u03b1\/VEGFB\/FGF2\/FGFR1 signaling pathway for ovarian cancer treatment","volume":"16","author":"Wang","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2013.08.032","article-title":"Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis","volume":"439","author":"Wang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2026.218361_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155612","article-title":"Targeting FGFR1 by \u03b2,\u03b2-dimethylacrylalkannin suppresses the proliferation of colorectal cancer in cellular and xenograft models","volume":"129","author":"Zhao","year":"2024","journal-title":"Phytomed: Int J Phytother Phytopharm"},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/19336918.2020.1766308","article-title":"FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer","volume":"14","author":"Yang","year":"2020","journal-title":"Cell Adhes. Migrat."},{"issue":"1","key":"10.1016\/j.canlet.2026.218361_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:41:24Z","timestamp":1776858084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"alternative-id":["S0304383526001242"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218361","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting FGFR1-regulated SPP1 signaling repolarizes immunosuppressive macrophages and sensitizes Hepatocellular Carcinoma to anti-PD-1 therapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218361"}}